Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

By conferring systemic protection and durable benefits, cancer immunotherapies are emerging as long-term solutions for cancer treatment. One such approach that is currently undergoing clinical testing is a therapeutic anti-cancer vaccine that uses two different viruses expressing the same tumor anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, D. G., Geoffroy, K., Marguerie, M., Khan, S. T., Martin, N. T., Kmiecik, J., Bobbala, D., Aitken, A. S., de Souza, C. T., Stephenson, K. B., Lichty, B. D., Auer, R. C., Stojdl, D. F., Bell, J. C., Bourgeois-Daigneault, M.-C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113265/
https://www.ncbi.nlm.nih.gov/pubmed/33976179
http://dx.doi.org/10.1038/s41467-021-22929-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113265/
https://www.ncbi.nlm.nih.gov/pubmed/33976179
http://dx.doi.org/10.1038/s41467-021-22929-z

Ejemplares similares